TREATMENT PATTERNS AND HEALTH CARE COSTS IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL) OR MARGINAL ZONE LYMPHOMA (MZL)TREATMENT PATTERNS AND HEALTH CARE COSTS IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL) OR MARGINAL ZONE LYMPHOMA (MZL)

被引:0
|
作者
Clancy, Z. [1 ]
Bell, E. [2 ]
Chastek, B. [3 ]
Bunner, S. [3 ]
Copher, R. [1 ]
Arekapudi, S. [4 ]
机构
[1] Bristol Myers Squibb, Summit, NJ USA
[2] Optum, Minneapolis, MN USA
[3] Optum, Eden Prairie, MN USA
[4] Univ Calif San Francisco, Fresno, CA USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCN104
引用
收藏
页码:S41 / S41
页数:1
相关论文
共 50 条
  • [41] DIFFERENTIATING FOLLICULAR LYMPHOMA FROM NODAL MARGINAL ZONE LYMPHOMA BY FLOW CYTOMETRY
    Maris, N. L.
    Thomas, A.
    Stanton, D.
    Wood, B.
    Fromm, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (01) : 201 - 201
  • [42] Cost of follicular lymphoma (FL) in Medicare patients
    Gleeson, M.
    Carolina, R.
    Danese, M.
    Knopf, K. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] Lymphoma-Related Quality of Life (QOL) Is Not Impacted By Initial Treatment Choice in Patients with Marginal Zone Lymphoma (MZL): Results from the Prospective Lymphoma Epidemiology of Outcomes (LEO) Cohort
    Bommier, Come
    Tsang, Mazie
    Noble, Brie N.
    Thompson, Carrie
    Casulo, Carla
    Hildebrandt, Michelle
    Rosenthal, Allison C.
    Mou, Eric
    Durani, Urshila
    Williams, Annalynn M.
    Yost, Kathleen
    Larson, Melissa C.
    Gysbers, Brianna
    Maurer, Matthew J.
    Feldman, Andrew L.
    Jaye, David L.
    Martin, Peter
    Cohen, Jonathon B.
    Chihara, Dai
    Lossos, Izidore S.
    Strouse, Christopher
    Kahl, Brad S.
    Habermann, Thomas M.
    Flowers, Christopher R.
    Dueck, Amylou Constance
    Cerhan, James R.
    BLOOD, 2023, 142
  • [44] Diagnosis and treatment of marginal zone lymphoma
    Cogliatti, Sergio
    Bargetzi, Mario
    Bertoni, Francesco
    Hitz, Felicitas
    Lohri, Andreas
    Mey, Ulrich
    Papachristofilou, Alexandros
    Taverna, Christian
    Zucca, Emanuele
    Renner, Christoph
    SWISS MEDICAL WEEKLY, 2016, 146 : 1S - 12S
  • [45] TREATMENT OF SPLENIC MARGINAL ZONE LYMPHOMA
    Julhakyan, H.
    Grjimolovskiy, A.
    Karagulyan, S.
    Magomedova, A.
    Kremenetskaya, A.
    Kravchenko, S.
    Obukhova, T.
    Kaplanskaya, I.
    Samoylova, R.
    Vorobjev, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 622 - 622
  • [46] Treatment of splenic marginal zone lymphoma
    Kalpadakis, Christina
    Pangalis, Gerassimos A.
    Angelopoulou, Maria K.
    Vassilakopoulos, Theodoros P.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2017, 30 (1-2) : 139 - 148
  • [47] Secreted factors determine resistance to idelalisib in splenic marginal zone lymphoma (MZL) models
    Arribas, A. J.
    Napoli, S.
    Cascione, L.
    Sartori, G.
    Gaudio, E.
    Tarantelli, C.
    Mensah, A. A.
    Spriano, F.
    Zucchetto, A.
    Rossi, F. M.
    Rinaldi, A.
    Jovic, S.
    Stathis, A.
    Stussi, G.
    Gattei, V.
    Brown, J. R.
    Esteller, M.
    Zucca, E.
    Rossi, D.
    Bertoni, F.
    ANNALS OF ONCOLOGY, 2021, 32 : S779 - S779
  • [48] Treatment Options for Marginal Zone Lymphoma
    Zucca, Emanuele
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S112 - S114
  • [49] Efficacy of 90Y-Ibritumomab Tiuxetan in marginal-zone lymphoma (MZL)
    Vanazzi, Anna
    Ferrucci, Pier Francesco
    Grana, Chiara
    Pruneri, Giancarlo
    Crosta, Cristiano
    Pinto, Antonello
    Chinol, Marco
    Paganelli, Giovanni
    Martinelli, Giovanni
    BLOOD, 2007, 110 (11) : 196B - 197B
  • [50] Copanlisib plus rituximab versus rituximab plus placebo in patients with relapsed follicular (FL) or marginal zone lymphoma (MZL): Subset analysis from the phase III CHRONOS-3 trial.
    Matasar, Matthew J.
    Capra, Marcelo
    Ozcan, Muhit
    Lv, Fangfang
    Li, Wei
    Yanez, Eduardo
    Sapunarova, Katya
    Lin, Tongyu
    Jin, Jie
    Jurczak, Wojciech
    Hamed, Aryan
    Wang, Ming-Chung
    Soler, Lidia Mongay
    Cao, Anjun
    Phelps, Charles
    Childs, Barrett H.
    Shi, Yuankai
    Zinzani, Pier Luigi
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)